Successful management of chronic myeloid leukemia with a complication of anti-SRP antibody-associated myopathy

MeSH terms

• Autoantibodies / immunology*
• Autoantigens / immunology*
• Biomarkers
• Disease Management
• Humans
• Imatinib Mesylate / adverse effects
• Imatinib Mesylate / therapeutic use
• Immunoglobulins, Intravenous / therapeutic use
• Immunosuppressive Agents / therapeutic use
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology*
• Male
• Middle Aged
• Muscular Diseases / diagnosis*
• Muscular Diseases / etiology*
• Muscular Diseases / therapy
• Signal Recognition Particle / immunology*
• Treatment Outcome